AutologIX, is an innovative therapy that utilizes your own body’s natural healing properties to promote regeneration and tissue repair. This cutting-edge treatment involves isolating exosomes, tiny membrane-bound vesicles, from your own platelets and delivering them directly to the area in need of treatment. Autologix’s exosomes contain a powerful mix of growth factors and signalings molecules that can stimulate healing, reduce inflammation, and promote tissue regeneration. Autologix represents a personalized approach to regenerative medicine that harnesses the body’s own healing potential to accelerate recovery and restore function. If you’re looking for a safe, effective, and minimally invasive alternative to traditional treatments, AutologIX’s autologous platelet exosome therapy may be the solution you’ve been searching for.
PROTSmart 6 is the result of a combination between the filtration technology based on capillary membranes and the concentration of blood derived plasma. ProtSmart is designed to collect and hyper-concentrate autologous exosomes from peripheral blood to be used in the field of regenerative medicine. It is a medical device Class IIa, a selective concentrator of exosome through an innovative technology of ultrafiltration . The filtration cut-off is close to ⏈15 KDa with average perfusion diameter < 5nm. Due to its selective ability to concentrate and ultrafilter, water and fragments of salt ions are pushed out in the bag while exosomes, proteins and cells are collected internally into the tubes. During centrifugation of IDRIA G exosomes are released and remain suspended in the plasma. The physicians process 2x IDRIA G 28ml tube which would give 27-28ml of Plasma in a single 8-minute spin(1500 rgf).
The autologous platelet exosomes therapy has shown potential benefits in various clinical settings. Some of the clinical benefits are:
Accelerated healing:
Autologous platelet exosomes therapy has been shown to accelerate the healing process by stimulating tissue regeneration and repair. The exosomes contain growth factors and signalling molecules that promote cell proliferation, migration, and differentiation, leading to faster tissue regeneration.
Reduced inflammation:
Inflammation is a natural response to injury, but excessive or chronic inflammation can impede the healing process. Autologous platelet exosomes therapy has been shown to reduce inflammation by suppressing the release of pro-inflammatory cytokines and promoting the release of anti-inflammatory cytokines.
Pain relief:
Autologous platelet exosomes therapy may help alleviate pain associated with various conditions, such as osteoarthritis, tendinopathy, and sports injuries. The therapy may work by promoting tissue repair and inflammation reduction, which can help relieve pain.
Minimally invasive:
Autologous platelet exosomes therapy is a minimally invasive treatment that can be performed in an outpatient setting. The therapy involves extracting a small amount of blood from the patient, processing it to isolate the exosomes, and then injecting the exosomes directly into the affected area.
Personalized treatment:
Autologous platelet exosomes therapy is a personalized treatment that utilizes the patient’s own blood as the source of the exosomes. This reduces the risk of adverse reactions and ensures that the exosomes are tailored to the patient’s specific needs.
Musculoskeletal injuries
Wound healing
Skin rejuvenation
Pain management
Hair loss
